It implies that CTRP9 can regulate the activity of AMPK, Akt and p42/44 mitogen‐activated protein kinase (MAPK), as well as reduction of microangiopathies, and bulk vascular diseases during the progression of diabetes.49 The gene discussed is C1QTNF9; the disease is diabetes mellitus.